Indeed, we and others have shown that inhibition of SPDEF expression in prostate cancer cells reduces adhesion and increases migration, invasion and EMT, while overexpression prevents these functions indicating a role of SPDEF in prostate cancer metastasis, but with apparent opposite activity to ERG [5, 6, 12]. The gene discussed is SPDEF; the disease is prostate carcinoma.